Literature DB >> 1743214

Optic gliomas in children with neurofibromatosis type 1.

A M Lund1, F Skovby.   

Abstract

Over a 24-year period, optic gliomas were found in 29 children, 16 of whom had neurofibromatosis type 1 (NF-1). These 16 children comprised 21% of all children referred for management of NF-1 and its complications. The finding of optic glioma led to the diagnosis of NF-1 in 4 children. The mean age at diagnosis of optic glioma in NF-1 children was 6.4 years, and the average estimated duration of visual symptoms prior to diagnosis was 2.1 years. Most optic gliomas in NF-1 children were ascertained because of a visual complaint (69%), and an even greater number of children (88%) had an abnormal ophthalmological examination. The optic chiasm was involved in 75% of the patients. All of the seven children with optic glioma examined by visual evoked potential had an abnormal response ipsilateral to the tumour. The majority of the children received radiation therapy. After a mean follow up period of 5.8 years no deaths had occurred due to optic glioma, but in 35% of the children vision was worse. We conclude that optic glioma is a common, serious complication in NF-1 children. Routine care of such patients should include regular noninvasive investigations aimed at detecting lesions of the optic pathway.

Entities:  

Mesh:

Year:  1991        PMID: 1743214     DOI: 10.1007/bf01955002

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  13 in total

Review 1.  Neurofibromatosis type 1 in childhood.

Authors:  R Listernick; J Charrow
Journal:  J Pediatr       Date:  1990-06       Impact factor: 4.406

2.  Childhood chiasmal gliomas: update on the fate of patients in the 1969 San Francisco Study.

Authors:  R K Imes; W F Hoyt
Journal:  Br J Ophthalmol       Date:  1986-03       Impact factor: 4.638

3.  Chiasmal gliomas: appearance and long-term changes demonstrated by computerized tomography.

Authors:  W A Fletcher; R K Imes; W F Hoyt
Journal:  J Neurosurg       Date:  1986-08       Impact factor: 5.115

4.  Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference.

Authors: 
Journal:  Arch Neurol       Date:  1988-05

5.  MR imaging of optic pathways in patients with neurofibromatosis.

Authors:  E W Brown; V M Riccardi; M Mawad; S Handel; A Goldman; R N Bryan
Journal:  AJNR Am J Neuroradiol       Date:  1987 Nov-Dec       Impact factor: 3.825

6.  von Recklinghausen neurofibromatosis. II. Incidence of optic gliomata.

Authors:  R A Lewis; L P Gerson; K A Axelson; V M Riccardi; R P Whitford
Journal:  Ophthalmology       Date:  1984-08       Impact factor: 12.079

Review 7.  Isolated optic nerve gliomas in children with and without neurofibromatosis.

Authors:  P K Duffner; M E Cohen
Journal:  Neurofibromatosis       Date:  1988

8.  Brain tumors in children with von Recklinghausen neurofibromatosis.

Authors:  H Hochstrasser; E Boltshauser; A Valavanis
Journal:  Neurofibromatosis       Date:  1988

9.  Optic gliomas in children with neurofibromatosis type 1.

Authors:  R Listernick; J Charrow; M J Greenwald; N B Esterly
Journal:  J Pediatr       Date:  1989-05       Impact factor: 4.406

10.  The value of visual evoked potential as a screening test in neurofibromatosis.

Authors:  B Jabbari; C G Maitland; L M Morris; J Morales; C H Gunderson
Journal:  Arch Neurol       Date:  1985-11
View more
  17 in total

1.  Optic pathway glioma: correlation of imaging findings with the presence of neurofibromatosis.

Authors:  L Kornreich; S Blaser; M Schwarz; A Shuper; T H Vishne; I J Cohen; R Faingold; S Michovitz; B Koplewitz; G Horev
Journal:  AJNR Am J Neuroradiol       Date:  2001 Nov-Dec       Impact factor: 3.825

2.  MRI internal segmentation of optic pathway gliomas: clinical implementation of a novel algorithm.

Authors:  Ben Shofty; Lior Weizman; Leo Joskowicz; Shlomi Constantini; Anat Kesler; Dafna Ben-Bashat; Michal Yalon; Rina Dvir; Sigal Freedman; Jonathan Roth; Liat Ben-Sira
Journal:  Childs Nerv Syst       Date:  2011-03-31       Impact factor: 1.475

Review 3.  Optic Pathway Gliomas in Neurofibromatosis Type 1: An Update: Surveillance, Treatment Indications, and Biomarkers of Vision.

Authors:  Peter M K de Blank; Michael J Fisher; Grant T Liu; David H Gutmann; Robert Listernick; Rosalie E Ferner; Robert A Avery
Journal:  J Neuroophthalmol       Date:  2017-09       Impact factor: 3.042

4.  Delayed diagnosis of childhood low-grade glioma: causes, consequences, and potential solutions.

Authors:  Aska Arnautovic; Catherine Billups; Alberto Broniscer; Amar Gajjar; Frederick Boop; Ibrahim Qaddoumi
Journal:  Childs Nerv Syst       Date:  2015-03-06       Impact factor: 1.475

Review 5.  Ophthalmological manifestations in VHL and NF 1: pathological and diagnostic implications.

Authors:  Klaus-Martin Kreusel
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

Review 6.  Role of visual evoked potentials in the assessment and management of optic pathway gliomas in children.

Authors:  C Van Mierlo; W Spileers; E Legius; I Casteels; C Cassiman
Journal:  Doc Ophthalmol       Date:  2013-07-25       Impact factor: 2.379

7.  NG2-cells are not the cell of origin for murine neurofibromatosis-1 (Nf1) optic glioma.

Authors:  A C Solga; S M Gianino; D H Gutmann
Journal:  Oncogene       Date:  2013-01-14       Impact factor: 9.867

8.  Rapid development of optic glioma in a patient with hybrid phakomatosis: neurofibromatosis type 1 and tuberous sclerosis.

Authors:  Sami H Erbay; Stephen A Oljeski; Rafeeque Bhadelia
Journal:  AJNR Am J Neuroradiol       Date:  2004-01       Impact factor: 3.825

9.  Visual function assessed by visually evoked potentials in optic pathway low-grade gliomas with and without neurofibromatosis type 1.

Authors:  Patrícia de Freitas Dotto; Adriana Berezovsky; Andrea Maria Cappellano; Nasjla Saba da Silva; Paula Yuri Sacai; Frederico Adolfo B Silva; Arthur Gustavo Fernandes; Daniel Martins Rocha; Solange Rios Salomão
Journal:  Doc Ophthalmol       Date:  2018-05-15       Impact factor: 2.379

10.  Central nervous system imaging in reevaluation of patients with neurofibromatosis type 1.

Authors:  P Balestri; L Calistri; R Vivarelli; G Bartalini; L Mancini; A Berardi; A Fois
Journal:  Childs Nerv Syst       Date:  1993-12       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.